ISFR:LSE:LSE-iShares MSCI France UCITS (GBX)

ETF | Others |

Last Closing

USD 5086.5

Change

+156.50 (+3.17)%

Market Cap

USD 0.16B

Volume

872.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

+151.00 (+0.80%)

USD 292,109.69B
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+5.35 (+2.23%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

-6.50 (-3.07%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.38 (+2.13%)

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.14 (+0.96%)

USD 636.56B
0R1I:LSE NVIDIA Corp.

+2.48 (+2.21%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-1.25 (-1.75%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

+0.68 (+2.27%)

USD 260.39B
0QZO:LSE 0QZO

-0.30 (-0.28%)

USD 258.54B

ETFs Containing ISFR:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.26% 91% A- 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.26% 91% A- 85% B
Trailing 12 Months  
Capital Gain 4.91% 44% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.91% 40% F 48% F
Trailing 5 Years  
Capital Gain 68.65% 72% C 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 68.65% 70% C- 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 12.25% 68% D+ 71% C-
Dividend Return 12.25% 67% D+ 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.57% 57% F 74% C
Risk Adjusted Return 97.40% 87% B+ 92% A
Market Capitalization 0.16B 56% F 32% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike